Advanced Search

Technical Analysis for NRXP - NeuroRx, Inc.

Grade Last Price % Change Price Change
F 11.43 12.39% 1.26
NRXP closed down 0.88 percent on Monday, October 18, 2021, on 46 percent of normal volume.
8 Watchers
Watchlist Portfolio

Trend Table & Recent EOD Trading Signals

ADX Long Term Intermediate Term Short Term
Weak or Absent Down Down Up
Historical NRXP trend table...
Date Alert Name Type % Chg
Calm After Storm Range Contraction 12.39%
Wide Bands Range Expansion 12.39%
Wide Bands Range Expansion 11.40%
50 DMA Resistance Bearish -4.03%
Non-ADX 1,2,3,4 Bearish Bearish Swing Setup -4.03%
Pocket Pivot Bullish Swing Setup -4.03%
Volume Surge Other -4.03%
Calm After Storm Range Contraction -4.03%
Doji - Bearish? Reversal -4.03%
Wide Bands Range Expansion -4.03%
Older End-of-Day Signals for NRXP ...

   Recent Intraday Alerts -- Get these alerts pushed to you via our Mobile App

Alert Time
Up 1 ATR 37 minutes ago
Up 10% about 1 hour ago
Rose Above Previous Day's High about 2 hours ago
60 Minute Opening Range Breakout about 2 hours ago
Up 5% about 3 hours ago
View Earlier Intraday Alerts

Get a Trading Sidekick!

Let us help you stay on top of your investments. We will alert you to important technical developments on your portfolio & watchlist.
Get Started for Free!
Configure default chart indicators Basic chart:

Profile

NeuroRx, Inc. operates as a clinical stage-small molecule pharmaceutical company which develops novel therapeutics for the treatment of central nervous system disorders. Its drug candidate includes Cyclurad, an oral therapeutic for the treatment of acute/elevated suicidal ideation/crisis in bipolar depression. The company was incorporated in 2015 and is headquartered in Wilmington, Delaware.
Classification
Sector: Industrials
Industry: Conglomerates
Keywords: Life Sciences Pharmaceutical Industry Health Sciences Health Care Central Nervous System Disorders Bipolar Disorder Antidepressants Treatment Of Central Nervous System Disorders Atypical Antipsychotics Bipolar Depression

Is NRXP a Buy, Sell or Hold?

Indicator Bull Case Neutral / Hold Bear Case
50 DMA
200 DMA
ADX Trend
Oversold / Overbought
Relative Strength
Counts: 0 bullish, 3 bearish and 2 neutral indicators. You may wish to incorporate that into your trading strategies.

Recent News

Date Title
Oct 14 NRx Pharma jumps 36% on positive aviptadil data in Critical COVID-19
Oct 14 Journal of Infectious Diseases and Treatment Publishes Positive Trial Data of Aviptadil in High Comorbidity Patients Suffering from Critical COVID-19 with Respiratory Failure
Oct 13 NRx Pharma issues update on legal dispute with Relief Therapeutics
Oct 12 NRx Pharma up 35% on supply arrangement for COVID-19 respiratory failure candidate
Oct 12 NRx Pharma issues update on global development of Zyesami
Oct 12 NRx Pharmaceuticals Announces Progress on Worldwide Commercial Scale Development of ZYESAMI™ (aviptadil)
Oct 12 NRx And Relief: Avoid Buying The Dips
Oct 8 The Daily Biotech Pulse: Allogene Sinks On FDA Clinical Hold, Takeda Gets Adcom Backing, Quidel Reports Q3 COVID Revenues, IPOs
Oct 7 NRx Pharmaceuticals reaches 52-week low; shares down 43% in last month
Sep 29 NRx Pharma says no new safety concerns in late-stage trial for COVID-19 therapy
See more NRXP news...

Indicators

Indicator Value
52 Week High 76.99
52 Week Low 6.43
Average Volume 3,416,359
200-Day Moving Average 24.17
50-Day Moving Average 11.90
20-Day Moving Average 9.38
10-Day Moving Average 9.15
Average True Range 1.52
ADX 17.51
+DI 36.45
-DI 20.50
Chandelier Exit (Long, 3 ATRs) 8.94
Chandelier Exit (Short, 3 ATRs) 10.98
Upper Bollinger Bands 11.81
Lower Bollinger Band 6.95
Percent B (%b) 0.66
BandWidth 51.82
MACD Line -0.50
MACD Signal Line -0.89
MACD Histogram 0.396
Fundamentals Value
Market Cap 27.34 Million
Num Shares 2.69 Million
EPS 0.02
Price-to-Earnings (P/E) Ratio 462.27
Price-to-Sales 0.00
Price-to-Book 9.15
Pivot Point Level Traditional / Classic Fibonacci Demark Woodie Camarilla
Resistance 4 (R4) 11.45
Resistance 3 (R3) 11.54 11.21 11.23
Resistance 2 (R2) 11.21 10.89 11.16 11.16
Resistance 1 (R1) 10.69 10.68 10.95 10.60 11.09
Pivot Point 10.36 10.36 10.49 10.31 10.36
Support 1 (S1) 9.84 10.04 10.10 9.75 9.25
Support 2 (S2) 9.51 9.83 9.46 9.18
Support 3 (S3) 8.99 9.51 9.11
Support 4 (S4) 8.90